Adverse effects of voriconazoleLOHR, Lisa.Orthopedics (Thorofare). 2004, Vol 27, Num 5, pp 472-473, issn 0147-7447, 2 p.Article

Voriconazole for serious fungal infectionsGOTHARD, P; ROGERS, T. R.International journal of clinical practice (Esher). 2004, Vol 58, Num 1, pp 74-80, issn 1368-5031, 7 p.Article

Comparison of microbiological and UV-spectrophotometric assays for determination of voriconazole in tabletsADAMS, Andrea I. H; STEPPE, Martin; FRÖEHLICH, Pedro E et al.Journal of AOAC International. 2006, Vol 89, Num 4, pp 960-965, issn 1060-3271, 6 p.Article

Clinical pharmacokinetics of voriconazoleLEVEQUE, Dominique; NIVOIX, Yasmine; JEHL, Francois et al.International journal of antimicrobial agents. 2006, Vol 27, Num 4, pp 274-284, issn 0924-8579, 11 p.Article

Voriconazole-induced pseudoporphyriaTOLLAND, J. P; MCKEOWN, P. P; CORBETT, J. R et al.Photodermatology photoimmunology & photomedicine. 2007, Vol 23, Num 1, pp 29-31, issn 0905-4383, 3 p.Article

Treatment of Scedosporiosis with Voriconazole : Clinical Experience with 107 PatientsTROKE, Peter; AGUIRREBENGOA, Koldo; ARTEAGA, Carmen et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 5, pp 1743-1750, issn 0066-4804, 8 p.Article

Successful topical therapy with voriconazole : Pseudallescheriasis after injuryTAMMER, Ina; SEIBOLD, Michael; KRAUSE, Hardy et al.The Journal of trauma, injury, infection, and critical care. 2007, Vol 62, Num 5, pp 1295-1297, issn 1079-6061, 3 p.Conference Paper

Successful treatment of brain aspergillosis with voriconazoleTATTEVIN, P; BRUNEEL, F; LELLOUCHE, F et al.Clinical microbiology and infection. 2004, Vol 10, Num 10, pp 928-931, issn 1198-743X, 4 p.Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

Voriconazole (Vfend®⁾ : une nouvelle arme contre les mycoses invasives = Voriconazole: a new weapon against invasive fungal infectionsAOUN, M.Revue médicale de Bruxelles. 2004, Vol 25, Num 3, pp 166-171, issn 0035-3639, 6 p.Article

EUCAST Technical Note on voriconazoleClinical microbiology and infection. 2008, Vol 14, Num 10, pp 985-987, issn 1198-743X, 3 p.Article

Invasive sphenoidal aspergillosis : Successful treatment with sphenoidotomy and voriconazoleBAUMANN, Ariane; ZIMMERLI, Stefan; HÄUSLER, Rudolf et al.ORL. 2007, Vol 69, Num 2, pp 121-126, issn 0301-1569, 6 p.Article

Voriconazole Use for Endemic Fungal Infections 7FREIFELD, Alison; PROIA, Laurie; ANDES, David et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 4, pp 1648-1651, issn 0066-4804, 4 p.Article

Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patientROBATEL, C; RUSCA, M; PADOIN, C et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 1, pp 269-270, issn 0305-7453, 2 p.Article

Effet rebond après utilisation du voriconazole dans le traitement de l'ABPA = Rebound after ABPA treatment with voriconazoleMULLIEZ, P; CROXO, C; SAINT-GEORGES, F.-R et al.Revue des maladies respiratoires. 2010, Vol 27, Num 7, pp 786-787, issn 0761-8425, 2 p.Article

Voriconazole Pharmacokinetics in Liver Transplant RecipientsJOHNSON, H. J; HAN, K; ROMKES, M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 852-859, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intracameral Voriconazole InjectionSHEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2156-2157, issn 0066-4804, 2 p.Article

Clearance of intravitreal voriconazoleSBEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 5, pp 2238-2241, issn 0146-0404, 4 p.Article

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazolePFALLER, M. A; ESPINEL-INGROFF, A; JONES, R. N et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4577-4580, issn 0095-1137, 4 p.Article

Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene bluePFALLER, M. A; BARRY, A; BILLE, J et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 4, pp 1716-1718, issn 0095-1137, 3 p.Article

Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patientsHAYLETT, A. K; FELTON, S; DENNING, D. W et al.British journal of dermatology (1951). 2013, Vol 168, Num 1, pp 179-185, issn 0007-0963, 7 p.Article

Susceptibility of filamentous fungi to voriconazole tested by two microdilution methodsLINARES, Maria José; CHARRIEL, Guadalupe; SOLIS, Francisco et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 1, pp 250-253, issn 0095-1137, 4 p.Article

Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazolePFALLER, M. A; BOYKEN, L; MESSER, S. A et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 3, pp 1288-1289, issn 0095-1137, 2 p.Article

Voriconazole: a new therapeutic agent with an extended spectrum of antifungal activityDONNELLY, J. P; DE PAUW, B. E.Clinical microbiology and infection. Supplement. 2004, Vol 10, Num 1, pp 107-117, issn 1470-9465, 11 p.Article

Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese populationIMATAKI, Osamu; OHNISHI, Hiroaki; KITANAKA, Akira et al.International journal of hematology. 2008, Vol 88, Num 1, pp 3-6, issn 0925-5710, 4 p.Article